These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8936356)

  • 1. Treatment of diabetic polyneuropathy with the neurotrophic peptide ORG 2766.
    Valk GD; Kappelle AC; Tjon-A-Tsien AM; Bravenboer B; Bakker K; Michels RP; Groenhout CM; Bertelsmann FW
    J Neurol; 1996 Mar; 243(3):257-63. PubMed ID: 8936356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, multicenter, double-blind, placebo-controlled, dose-finding study of ORG 2766 in the prevention or delay of cisplatin-induced neuropathies in women with ovarian cancer.
    Roberts JA; Jenison EL; Kim K; Clarke-Pearson D; Langleben A
    Gynecol Oncol; 1997 Nov; 67(2):172-7. PubMed ID: 9367703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized double-blind placebo-controlled trial to evaluate the effect of the ACTH4-9 analogue ORG 2766 in IDDM patients with neuropathy.
    Bravenboer B; Hendrikse PH; Oey PL; van Huffelen AC; Groenhout C; Gispen WH; Erkelens DW
    Diabetologia; 1994 Apr; 37(4):408-13. PubMed ID: 8063043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group.
    Apfel SC; Schwartz S; Adornato BT; Freeman R; Biton V; Rendell M; Vinik A; Giuliani M; Stevens JC; Barbano R; Dyck PJ
    JAMA; 2000 Nov; 284(17):2215-21. PubMed ID: 11056593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of Org 2766 in treatment of peripheral neuropathy in streptozocin-induced diabetic rats.
    Van der Zee CE; Van der Hoop RG; Gispen WH
    Diabetes; 1989 Feb; 38(2):225-30. PubMed ID: 2536628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for assessing diabetic polyneuropathy: validity and reproducibility of the measurement of sensory symptom severity and nerve function tests.
    Valk GD; Grootenhuis PA; van Eijk JT; Bouter LM; Bertelsmann FW
    Diabetes Res Clin Pract; 2000 Feb; 47(2):87-95. PubMed ID: 10670907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind placebo-controlled clinical trial of recombinant human brain-derived neurotrophic factor (rhBDNF) in diabetic polyneuropathy.
    Wellmer A; Misra VP; Sharief MK; Kopelman PG; Anand P
    J Peripher Nerv Syst; 2001 Dec; 6(4):204-10. PubMed ID: 11800042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The course of neuropathy after cessation of cisplatin treatment, combined with Org 2766 or placebo.
    Hovestadt A; van der Burg ME; Verbiest HB; van Putten WL; Vecht CJ
    J Neurol; 1992 Mar; 239(3):143-6. PubMed ID: 1315383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.
    Ziegler D; Hanefeld M; Ruhnau KJ; Hasche H; Lobisch M; Schütte K; Kerum G; Malessa R
    Diabetes Care; 1999 Aug; 22(8):1296-301. PubMed ID: 10480774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited benefit of treatment of diabetic polyneuropathy with an aldose reductase inhibitor: a 24-week controlled trial.
    Fagius J; Brattberg A; Jameson S; Berne C
    Diabetologia; 1985 Jun; 28(6):323-9. PubMed ID: 3930330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for the use of the ACTH4-9 analogue ORG 2766 in the treatment of diabetic neuropathy.
    Bravenboer B; Erkelens DW; Gispen WH
    Neth J Med; 1992 Dec; 41(5-6):255-8. PubMed ID: 1337372
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of ubiquinone in diabetic polyneuropathy: a randomized double-blind placebo-controlled study.
    Hernández-Ojeda J; Cardona-Muñoz EG; Román-Pintos LM; Troyo-Sanromán R; Ortiz-Lazareno PC; Cárdenas-Meza MA; Pascoe-González S; Miranda-Díaz AG
    J Diabetes Complications; 2012; 26(4):352-8. PubMed ID: 22595020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.
    Ametov AS; Barinov A; Dyck PJ; Hermann R; Kozlova N; Litchy WJ; Low PA; Nehrdich D; Novosadova M; O'Brien PC; Reljanovic M; Samigullin R; Schuette K; Strokov I; Tritschler HJ; Wessel K; Yakhno N; Ziegler D;
    Diabetes Care; 2003 Mar; 26(3):770-6. PubMed ID: 12610036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group.
    Apfel SC; Kessler JA; Adornato BT; Litchy WJ; Sanders C; Rask CA
    Neurology; 1998 Sep; 51(3):695-702. PubMed ID: 9748012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer.
    van der Hoop RG; Vecht CJ; van der Burg ME; Elderson A; Boogerd W; Heimans JJ; Vries EP; van Houwelingen JC; Jennekens FG; Gispen WH
    N Engl J Med; 1990 Jan; 322(2):89-94. PubMed ID: 2152972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benfotiamine in the treatment of diabetic polyneuropathy--a three-week randomized, controlled pilot study (BEDIP study).
    Haupt E; Ledermann H; Köpcke W
    Int J Clin Pharmacol Ther; 2005 Feb; 43(2):71-7. PubMed ID: 15726875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens.
    Wymer JP; Simpson J; Sen D; Bongardt S;
    Clin J Pain; 2009 Jun; 25(5):376-85. PubMed ID: 19454870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sorbinil therapy in diabetic patients with painful peripheral neuropathy and autonomic neuropathy.
    Jaspan JB; Herold K; Bartkus C
    Am J Med; 1985 Nov; 79(5A):24-37. PubMed ID: 3000176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized, Double-Blind Study of the Effects of a Sustained Release Formulation of Sodium Nitrite (SR-nitrite) on Patients with Diabetic Neuropathy.
    Soin A; Bock G; Giordano A; Patel C; Drachman D
    Pain Physician; 2018 Mar; 21(2):179-190. PubMed ID: 29565948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of symptomatic polyneuropathy with actovegin in type 2 diabetic patients.
    Ziegler D; Movsesyan L; Mankovsky B; Gurieva I; Abylaiuly Z; Strokov I
    Diabetes Care; 2009 Aug; 32(8):1479-84. PubMed ID: 19470838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.